Abstract
Ehlers-Danlos syndrome (EDS) is a heterogeneous group of connective tissue heritable disorders. EDS type IV is a rare form that presents typical clinical signs, such as easy bruising and haematomas at sites of trauma, skin manifestations (translucent skin with visible veins), and joint hyperlaxity. To illustrate the dermatological features and describe an aggressive periodontitis, a symptom not yet reported in this EDS type, we present a case of a 23-year-old young man. This patient has been suffering from bruised skin, haematomas, and varicose veins in his legs. These lesions, typical of EDS type IV, were associated with trauma followed by slow and difficult cicatrization. Teeth loss and clinical attachment loss in all the remaining teeth, a symptom compatible with a severe destruction of the periodontal support, was reported after orthodontic treatment. The treatment is limited to control the disease and teeth loss. Considering this new clinical symptom associated with EDS type IV, we suggest that the use of orthodontic apparatus should be carefully considered in such patients.
Similar content being viewed by others
References
Autio P, Turpeinen M, Risteli J, Kallioinen M, Kiistala U, Oikarinen A (1997) Ehlers-Danlos type IV: non-invasive techniques as diagnostic support. Br J Dermatol 137:653–655
Axelsson P, Nyström B, Lindhe J (2004) The long-term effect of a plaque control program on tooth mortality, caries and periodontal disease in adults. Results after 30 years of maintenance. J Clin Periodontol 31:749–757
Beighton P, DePaepe A, Steinmann B, Tsipouras P, Wenstrup RJ (1997) Ehlers-Danlos syndrome: revised nosology. Villefranche. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK) (1998). Am J Med Genet 77:31–37
Cikrit DF, Glover JR, Dalsing MC, Silver D (2002) The Ehlers-Danlos specter revisited. Vasc Endovascular Surg 36:213–217
Crowther MA, Lach B, Dunmore PJ, Roach MR (1991) Vascular collagen fibril morphology in type IV Ehlers-Danlos syndrome. Connect Tissue Res 25:209–217
De Coster PJ, Malfait F, Martens LC, De Paepe A (2003) Unusual oral findings in dermatosparaxis (Ehlers-Danlos syndrome type VIIC). J Oral Pathol & Med 32:568–570
De Felice C, Di Maggio G, Toti P, Parrini S, Salzano A, Lagrasta EU, Bagnoli F (2001) Infantile hypertrophic pyloric stenosis and asymptomatic joint hypermobility. J Pediatr 13:596–598
De Paepe A, Malfait F (2004) Bleeding and bruising in patients with Ehlers-Danlos syndrome and other collagen vascular disorders. Br J Haematol 127:491–500
Dyne KM, Vitellaro-Zuccarello L, Bacchella L, Lanzi G, Cetta G (1993) Ehlers-Danlos syndrome type VIII: biochemical, stereological and immunocytochemical studies on dermis from a child with clinical signs of Ehlers-Danlos syndrome and a family history of premature loss of permanent teeth. Br J Dermatol 128:458–463
Dunmore PJ, Roach MR (1990) The effects of age, vessel size, and Ehlers-Danlos type IV syndrome on the waviness index of arteries. Clin Invest Med 13:67–70
Eisenbeiss C, Martinez A, Hagedorn-Greiwe M, Reinhardt DP, Batge B, Brinckmann J (2003) Reduced skin thickness: a new minor diagnostic criterion for the classical and hypermobility types of Ehlers-Danlos syndrome. Br J Dermatol 149:850–852
Germain DP, Herrera-Guzman Y (2004) Vascular Ehlers-Danlos syndrome. Ann Genet 47:1–9
Hartsfield JK Jr, Kousseff BG (1990) Phenotypic overlap of Ehlers-Danlos syndrome types IV and VIII. Am J Med Genet 37:465–470
Karrer S, Landthaler M, Schmalz G (2000) Ehlers-Danlos type VIII review of the literature. Clin Oral Investig 4:66–69
Karrer S, Landthaler M, Schmalz G (2000) Ehlers-Danlos syndrome type VIII with severe periodontitis and apical root resorption after orthodontic treatment. Acta Derm-Venereol 80:56–57
Kinane DF, Peterson M, Stathopoulou PG (2006) Environmental and other modifying factors of the periodontal diseases. Periodontol 2000 40:107–119
Kroes HY, Pals G, van Essen AJ (2003) Ehlers-Danlos syndrome type IV: unusual congenital anomalies in a mother and son with a COL3A1 mutation and a normal collagen III protein profile. Clin Genet 63:224–227
Mantle D, Wilkins RM, Preedy V (2005) A novel therapeutic strategy for Ehlers-Danlos syndrome based on nutritional supplements. Med Hypotheses 64:279–283
McKusick VA et al (1998) Online Mendelian inheritance in man, OMIN™, MIM number 130020. Johns Hopkins University Press, Baltimore, MD (http://www.ncbi.nlm.nih.gov/omim/, date last edited: 05 Oct 2005)
Parrini S, Bellosi A, Barducci A, Bianciardi G, Latini G, De Felice C (2004) Abnormal oral light reflectance: a new clinical sign of Ehlers-Danlos syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endo 97:335–338
Pasmatzi E, Vlastos D, Monastirli A, Stephanou G, Georgious S, Sakkis T, Tsambaos D (2006) Ehlers-Danlos type IV syndrome in a patient with Down syndrome: simple co-occurrence or true association? Am J Med Sci 331:48–50
Perez LA, Al-Shammari KF, Giannobile WV, Wang HL (2002) Treatment of periodontal disease in a patient with Ehlers-Danlos syndrome. A case report and literature review. J Periodontol 73:564–570
Prahlow JA, Wagner SA (2005) Death due to Ehlers-Danlos Syndrome type IV. Am J Forensic Med Pathol 26:78–82
Rosling B, Serino G, Hellström MK, Socransky SS, Lindhe J (2001) Longitudinal periodontal tissue alterations during supportive therapy. Findings from subjects with normal and high susceptibility to periodontal disease. J Clin Periodontol 28:241–249
Schätzle M, Löe H, Bürgin W, Anerud A, Boysen H, Lang NP (2004) The clinical course of chronic periodontitis. J Clin Periodontol 31:1122–1127
Stillman AE, Painter R, Hollister DW (1991) Ehlers-Danlos syndrome type IV: diagnosis and therapy of associated bowel perforation. Am J Gastroenterol 86:360–362
Walker LC, Teebi AS, Marini JC, De Paepe A, Malfait F, Atsawasuwan P, Yamauchi M, Yeowell HN (2004) Decreased expression of lysyl hydroxylase 2 (LH2) in skin fibroblasts from three Ehlers-Danlos patients does not result from mutations in either the coding or proximal promoter region of the LH2 gene. Mol Genet Metab 83:312–321
Wang WM, Lee S, Steiglitz BM, Scott IC, Lebares CC, Allen ML, Brenner MC, Takahara K, Greenspan DS (2003) Transforming growth factor-beta induces secretion of activated ADAMTS-2. A procollagen III N-proteinase. J Biol Chem 278:19549–19557
Whitelaw SE (2004) Ehlers-Danlos syndrome, classical type: case management. Dermatol Nurs 16:433–436
Wimmer PJ, Howes DS, Rumoro DP, Carbone M (1996) Fatal vascular catastrophe in Ehlers-Danlos syndrome: a case report and review. J Emerg Med 14:25–31
Zweers MC, Van Vlijmen-Willems IM, van Kuppevelt TH, Mecham RP, Steijlen PM, Bristow J, Schalkwijk J (2004) Deficiency of tenascin-X causes abnormalities in dermal elastic fiber morphology. J Invest Dermatol 122:885–891
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Badauy, C.M., Gomes, S.S., Sant’Ana Filho, M. et al. Ehlers-Danlos Syndrome (EDS) type IV. Review of the literature. Clin Oral Invest 11, 183–187 (2007). https://doi.org/10.1007/s00784-006-0092-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00784-006-0092-x